When someone uses the term adult stem cells you might think that simply means stem cells from adults. However, its not that simple. The goal of todays post is to help you get all the key facts about adult stem cells. This includes the different types of adult stem cells and their clinical potential.
An adult stem cell has often been defined in a negative fashion. For instance, for years adult stem cells were considered by many to be stem cells that were not embryonic stem cells. This way of thinking was too broad. It ended up including induced pluripotent stem cells or iPS cells in the adult category. They dont belong there as pluripotent stem cells. And also what about fetal stem cells?
A more specific definition was needed.
Today my definition of adult stem cells is those stem cells derived from differentiated tissues. That can include stem cells from children and even infants. These cells are generally multipotent stem cells.
One of the most common types of adult stem cell goes by the acronym MSC. What MSC stands for is now debated, but at this point Id say the best explanation of MSC is mesenchymal stromal/stem cell. Its complicated because most preps of MSCs contain a mixture of both stem cells and non-stem cells.
One of the challenges with sourcing adult stem cells is that in isolating them from adult tissues you get a whole bunch of other cell types too. It isnt always easy or practical to 100% separate out the stem cells from the non-stem cells. As a result, when talking about cells like MSCs as mentioned earlier, oftentimes they are not pure populations.
MSCs can also be isolated from many tissues including bone marrow, fat, and the wall of the umbilical cord, just to name three.
Another common type of adult stem cell is hematopoietic stem cells such as from bone marrow or cord blood.
You can isolate adult stem cell-like cells from just about any differentiated tissues. Over the years there have been debates about whether certain tissues have stem cells. For a long time it was thought by most people that the mature brain did not have true stem cells in it. However, the consensus now is that it does. The same goes for lung stem cells.
Probably the most contentious discussion in this area today is whether the heart has any true or meaningful populations of stem cells. I doubt that there are meaningful endogenous populations of heart stem cells.
Skin stem cells are one of the more interesting types in the adult category. They have many potential clinical applications.
Because of the past debate about funding of embryonic stem cell research in the U.S. (and elsewhere), there ended up being this false dichotomy. Opponents of embryonic stem cell research created an us vs. them mentality. Embryonic stem cells vs. adult stem cells. The reality is that both adult stem cells and embryonic stem cells have clinical promise.
I hope that both types of cells are the basis for therapies that help many people.
Other types, such as iPS cells, have real promise too.
As mentioned earlier, the main difference between these types of stem cells is their potency. This means how many other kinds of cells they can turn into, which is called differentiation. Surprisingly, some researchers claim that there are pluripotent adult stem cells, but the research in this area is not convincing to me. If such cells existed in adult tissues, why dont they form stem cell-related tumors called teratomas? Also, why would adult tissues have pluripotent stem cells in them?
For instance, why would a lung have cells in it with the ability to make neurons, kidney, heart, bone, etc.? It just doesnt make sense.
One long-shot possibility is that while these cells do not naturally exist that the harsh isolation process of trying to get cells out of adult tissues causes some cells to seem like pluripotent cells for a time. This brings to mind the whole STAP cell fiasco. Even so, cellular stress is a very interesting area of research.
There is a vast array of clinical trials that in some way utilize adult multipotent stem cells. For MSCs alone, this week I found 709 trials for just one type of search on Clinicaltrials.gov. Because MSCs go by different names this likely an underestimation. On the other hand, some of these trials may be non-interventional. Other MSC trials dont use actual cells but instead are based on products derived from those cells like exosomes.
The most talked-about property of adult stem cells today is their ability to modulate immune responses. Many clinical trials including cell therapy trials for COVID-19 are based on this rationale.
Another therapeutic angle is that an adult stem cell sometimes can turn into another kind of cell. It may, for example, differentiate into fat, muscle, bone, cartilage, or skin cells. This differentiation property could be very useful too in the clinic. This means that we shouldnt get tunnel vision on the immunomodulation properties alone.
Overall, I see adult stem cells as promising for some specific diseases. We need strong, convincing data from clinical trials to be sure for any specific application.
Related Posts
See the article here:
What are adult stem cells & their clinical applications ...
- Biology of stem cells: an overview - PMC - National Center for ... - March 26th, 2024
- Iron Limitation Preserves Youthfulness of Blood Stem Cells - Mirage News - March 13th, 2024
- Mini organs grown from stem cells of unborn babies for the first time in breakthrough - The Mirror - March 9th, 2024
- The Effect of Short-Term NAD3 Supplementation on Circulating Adult Stem Cells in Healthy Individuals Aged 40-70 ... - Cureus - March 7th, 2024
- University of Liverpool Spin-Out Emerges, Pioneering Novel Adult Stem Cell-Based Therapies - India Education Diary - March 7th, 2024
- Scientists have used cells from fluid drawn during pregnancy to grow mini lungs and other organs - Yahoo News Canada - March 6th, 2024
- Japan approves new stem cell-based Alzheimer's therapy By Proactive Investors - Investing.com Australia - January 20th, 2024
- Cyberstalking pits Harvard professor against PubPeer Retraction ... - Retraction Watch - December 5th, 2023
- 10 functional health predictions for 2024, according to a doctor and ... - 1330 WFIN - December 5th, 2023
- See the Brain Like Never Before in This Gorgeous Art - Scientific American - December 5th, 2023
- Geron Announces Publication in The Lancet of Results from the ... - BioSpace - December 5th, 2023
- Stem cell injections could be the key to curing MS - Freethink - December 3rd, 2023
- Jaypirca (pirtobrutinib) Now Approved by U.S. FDA for the ... - Investors | Eli Lilly and Company - December 3rd, 2023
- Comparative Efficacy and Safety of Four JAK Inhibitors for ... - HealthDay - December 3rd, 2023
- City lights up for Francis on Anthony Nolan's birthday - Liverpool Express - December 3rd, 2023
- NOT-AR-23-022: Request for Information on Themes for the NIAMS ... - National Institutes of Health (.gov) - December 3rd, 2023
- December 2023: Intramural Papers of the Month - Environmental Factor Newsletter - December 1st, 2023
- CNA Explains: What is cord blood banking and why do parents do it? - CNA - December 1st, 2023
- Regulation of myogenesis and adipogenesis by the electromagnetic ... - Nature.com - December 1st, 2023
- The effects of vitamin K on bone health - News-Medical.Net - December 1st, 2023
- Dr Hurwitz on Ongoing Investigations of the Use of CAR T-Cell ... - OncLive - December 1st, 2023
- Mitophagy in human health, ageing and disease - Nature.com - December 1st, 2023
- Adult Stem Cells - Stem Cells and the Future of Regenerative Medicine ... - November 29th, 2023
- Navigating The Regulatory Landscape Of Longevity Health Products ... - Mondaq News Alerts - November 29th, 2023
- MS breakthrough could lead to treatments that halt disease's ... - inews - November 29th, 2023
- Reprogramming tissue mechanically to promote wound healing - Phys.org - November 29th, 2023
- Latest Advances in Arthritis Diagnosis and Treatment at American ... - HealthDay - November 29th, 2023
- Sex-associated differences in frequencies and prognostic impact of ... - Nature.com - November 29th, 2023
- Hematologists Dive into the Current Treatment Landscape - OncLive - November 29th, 2023
- Team discovers protein crucial for B cell differentiation and antibodies - Phys.org - November 29th, 2023
- Science Talk - I survived cancer as a child and now I'm working to ... - The Institute of Cancer Research - November 29th, 2023
- First Edition: Nov. 29, 2023 - KFF Health News - November 29th, 2023
- Symptoms: Unilateral Hearing Loss and Tinnitus : The Hearing Journal - LWW Journals - November 29th, 2023
- Mitigation of sepsis-induced acute lung injury by BMSCs | IJN - Dove Medical Press - November 29th, 2023
- A Case of a Constricted Vessel: The Impact of Acute Myeloid ... - Cureus - November 29th, 2023
- Mum brushed off fatigue after having baby but fall sparked deadly diagnosis - The Mirror - November 29th, 2023
- How heritable is the epigenome? - Drug Discovery News - November 29th, 2023
- The Blueprint of Regeneration: Scientists Discover How to Turn Stem Cells Fate - Revyuh - November 27th, 2023
- BrainStorm Cell Therapeutics Announces In-Person Meeting with ... - Marketscreener.com - November 27th, 2023
- Stem Cell Therapy Developed in Korea Begins Treatment for ... - PharmiWeb.com - November 25th, 2023
- COVID-19 Pandemic's Adverse Effect on Bone Health in Young ... - HealthDay - November 25th, 2023
- Sickle cell breakthrough - The Indian Express - November 25th, 2023
- Wall thickness analysis method for judging the degree of lower ... - Nature.com - November 25th, 2023
- Century Therapeutics to Present at the Piper Sandler 35th Annual Healthcare Conference - Yahoo Finance - November 23rd, 2023
- Disease Transmission and Diagnosis of Zika Virus - Cureus - November 23rd, 2023
- Gene-editing therapy for sickle cell earns conditional approval in UK - Sickle Cell Disease News - November 23rd, 2023
- Stem Cell Therapy Developed in Korea Begins Treatment for ... - Newswire - November 21st, 2023
- Efficacy of ADSC-CM in Patients with Telogen Effluvium | SCCAA - Dove Medical Press - November 21st, 2023
- BrainStorm Cell Therapeutics Announces In-Person Meeting with ... - PR Newswire - November 21st, 2023
- The Impact of CAR T Cell Therapy on Managing R/R LBCL - OncLive - November 21st, 2023
- Mansour bin Zayed witnesses inauguration of ADSCC Bone Marrow Transplant & Cellular Therapy Congress 2023 - ZAWYA - November 21st, 2023
- Listeria: Who is most susceptible? What are the Symptoms? What ... - Food Poison Journal - November 21st, 2023
- Scope Of Issued Patents May Be Limited By Prosecution Estoppel ... - Mondaq News Alerts - November 21st, 2023
- Qrons Announces the Addition of Professor Shiri Navon-Venezia to ... - StreetInsider.com - November 21st, 2023
- Financially strapped Athersys raises $10.4M - cleveland.com - November 19th, 2023
- From the India Today archives (2010) | How stem cells can save your life - India Today - November 19th, 2023
- Inactivation of the tumor suppressor gene Apc synergizes with H ... - Science - November 19th, 2023
- The Origins of Multiple Myeloma and Why it Matters - HealthTree For AML - Acute Myeloid Leukemia - November 19th, 2023
- Treatment Considerations With TROP2-Targeted Therapy - OncLive - November 19th, 2023
- Athersys narrows loss, raises $10.4 million during third quarter to ... - The Business Journals - November 17th, 2023
- Who was Dolly the Sheep and what happened to her? The story of ... - BBC Countryfile Magazine - November 17th, 2023
- UK first to approve CRISPR treatment for diseases: what you need to ... - Nature.com - November 17th, 2023
- 1st sickle cell patient to be given therapy restoring fetal hemoglobin - Sickle Cell Disease News - November 15th, 2023
- Century Therapeutics Reports Third Quarter 2023 Financial Results and Provides Business Updates - Century - Benzinga - November 13th, 2023
- Century Therapeutics Appoints Brent Pfeiffenberger, Pharm.D., MBA, as Chief Executive Officer - Yahoo Finance - November 11th, 2023
- Century Therapeutics and FUJIFILM Cellular Dynamics Announce Licenses for the Development and Commercialization of iPSC-Derived Cell Therapies in... - November 11th, 2023
- AAO 2023: Paul Runge and his ROP treatments in the Ukraine - Modern Retina - November 11th, 2023
- The Evolutionary Reasons We Are Drawn To Horror Movies and ... - Slashdot - November 11th, 2023
- Century Therapeutics Reports Third Quarter 2023 Financial Results ... - GlobeNewswire - November 11th, 2023
- Century Therapeutics Reports Third Quarter 2023 Financial Results ... - StreetInsider.com - November 9th, 2023
- NYU Langone Health Performs World's First Whole-Eye & Partial ... - NYU Langone Health - November 9th, 2023
- BrainStorm to Announce Third Quarter 2023 Financial Results and ... - BioSpace - November 9th, 2023
- Can we cut cost and pain of IVF? Start-up CEO tries out own ... - Genetic Literacy Project - November 9th, 2023
- Jasper Therapeutics Reports Third Quarter 2023 Financial Results ... - BioSpace - November 9th, 2023
- Impaired neural stress resistance and loss of REST in bipolar ... - Nature.com - November 9th, 2023
- Functional genomics and systems biology in human neuroscience - Nature.com - November 9th, 2023
- Trial launched to test CAR T-cell therapy in dogs diagnosed with ... - EurekAlert - November 9th, 2023
- The-Gut's-Lasting-Impact-on-Severe-COVID-19-Immune-Response - Infectious Disease Special Edition - November 9th, 2023
- Emerging Cure for Sickle Cell on its Way to FDA Approval, Carries ... - Dallasweekly - November 7th, 2023
- The science works, but will we pay for it? - Irish Medical Times - November 7th, 2023
Recent Comments